TARDBP and Cognitive impairment: We note that the primary underlying pathology contributing to cognitive impairment in probable DLB patients is α-synuclein, with additional β-amyloid, NFT-tau, and possibly other pathologies, such as vascular disease or TAR DNA-binding protein-43.